CBD Life Sciences Inc. (CBDL)
Makes and sells CBD products for pain, sleep, anxiety, and pets.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-33.3%
The outlook
CBD Life Sciences is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a sustained downtrend. Analyst coverage is thin, and the current sentiment leans decidedly bearish. The stock remains in the penny-stock range with minimal recent price movement.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$1.2M
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—